Portage Biotech Inc Financials
This page shows Portage Biotech Inc (PRTG) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Portage Biotech Inc does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
For every $1 of reported earnings, Portage Biotech Inc used $0.01 of operating cash (-$1.1M OCF vs $123.7M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.
Key Financial Metrics
Earnings & Revenue
Portage Biotech Inc reported $123.7M in net income in fiscal year 2018. This represents an increase of 659.2% from the prior year.
Portage Biotech Inc earned $0.46 per diluted share (EPS) in fiscal year 2018. This represents an increase of 666.7% from the prior year.
Not reported for fiscal year 2018.
Not reported for fiscal year 2018.
Cash & Balance Sheet
Portage Biotech Inc held $7.5M in cash as of fiscal year 2018; long-term debt is not reported for that period.
Not reported for fiscal year 2018.
Not reported for fiscal year 2018.
Margins & Returns
Portage Biotech Inc's ROE was 1286.4% in fiscal year 2018, measuring profit generated per dollar of shareholder equity. This is up 1259.1 percentage points from the prior year.
Not reported for fiscal year 2018.
Not reported for fiscal year 2018.
Not reported for fiscal year 2018.
Capital Allocation
None of these metrics is reported for fiscal year 2018.
PRTG Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY18 | FY17 | FY16 |
|---|---|---|---|
| Net Income | $123.7M+659.2% | $16.3M+385.6% | -$5.7M |
| EPS (Diluted) | $0.46+666.7% | $0.06+400.0% | -$0.02 |
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, Interest Expense, Income Tax.
PRTG Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY18 | FY17 | FY16 |
|---|---|---|---|
| Current Assets | $7.6M-87.1% | $59.1M | N/A |
| Cash & Equivalents | $7.5M+4629.6% | $159K-96.6% | $4.7M |
| Current Liabilities | $127K+16.5% | $109K | N/A |
| Total Equity | $9.6M-83.9% | $59.6M+383.4% | $12.3M |
| Retained Earnings | -$14.3M-195.7% | $15.0M | N/A |
Not reported in any period shown, so not listed: Total Assets, Inventory, Accounts Receivable, Goodwill, Total Liabilities, Long-Term Debt.
PRTG Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY18 | FY17 | FY16 |
|---|---|---|---|
| Operating Cash Flow | -$1.1M+18.8% | -$1.3M+77.4% | -$5.8M |
| Investing Cash Flow | $5.7M+266.0% | -$3.4M-100.5% | -$1.7M |
| Financing Cash Flow | $2.8M+1288.0% | $200K-98.1% | $10.5M |
Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.
PRTG Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY18 | FY17 | FY16 |
|---|---|---|---|
| Return on Equity | 1286.4%+1259.1pp | 27.4%+73.6pp | -46.3% |
| Current Ratio | 59.97-482.6x | 542.53 | N/A |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Assets, Debt-to-Equity, FCF Margin.
Similar Companies
Where Portage Biotech Inc Ranks
Frequently Asked Questions
Is Portage Biotech Inc profitable?
Yes, Portage Biotech Inc (PRTG) reported a net income of $123.7M in fiscal year 2018.
What is Portage Biotech Inc's return on equity (ROE)?
Portage Biotech Inc (PRTG) has a return on equity of 1286.4% for fiscal year 2018, measuring how efficiently the company generates profit from shareholder equity.
What is Portage Biotech Inc's operating cash flow?
Portage Biotech Inc (PRTG) recorded an outflow of $1.1M in operating cash flow during fiscal year 2018, representing cash used by core business activities.
What is Portage Biotech Inc's current ratio?
Portage Biotech Inc (PRTG) had a current ratio of 59.97 as of fiscal year 2018, which is generally considered healthy.
What is Portage Biotech Inc's cash runway?
Based on fiscal year 2018 data, Portage Biotech Inc (PRTG) had $7.5M in cash against an annual operating cash burn of $1.1M. This gives an estimated cash runway of approximately 84 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Are Portage Biotech Inc's earnings high quality?
For every $1 of reported earnings, Portage Biotech Inc (PRTG) used $0.01 of operating cash (-$1.1M OCF vs $123.7M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.